A MYELOID-TARGETED NOVEL THERAPEUTIC FOR GLOMERULAR DISEASES.

$5,099,737FY2025Defense Health AgencyDOD

149 Bio Llc

Investigators

View source on USAspending →

A MYELOID-TARGETED NOVEL THERAPEUTIC FOR GLOMERULAR DISEASES. · GrantIndex